1. 1. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
N Engl J Med 2016;374(17):1609-20. https://doi.org/10.1056/ NEJMoa1514616; PMID: 27040324.
2. 2. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;70(2):252-89. https://doi.org/10.1016/j. jacc.2017.03.011; PMID: 28315732.
3. 3. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38(36):2739-91. https://doi.org/10.1093/eurheartj/ ehx391; PMID: 28886619.
4. 4. Grover FL, Vemulapalli S, Carroll JD, et al. 2016 Annual Report of The Society of Thoracic Surgeons/American College
of Cardiology Transcatheter Valve Therapy Registry. J Am
Coll Cardiol 2017;69(10):1215-30. https://doi.org/10.1016/ j.jacc.2016.11.033; PMID: 27956264.
5. 5. Auffret V, Lefevre T, Van Belle E, et al. Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI. J Am Coll Cardiol 2017;70(1):42-55. https://doi. org/10.1016/j.jacc.2017.04.053; PMID: 28662806.